Minocycline-Induced Ocular Ochronosis
- PMID: 37700983
- PMCID: PMC10492665
- DOI: 10.7759/cureus.43307
Minocycline-Induced Ocular Ochronosis
Abstract
We report a case of minocycline-induced ocular ochronosis with scleral, retinal, and cutaneous manifestations. A 65-year-old male who had taken minocycline for four years to treat hidradenitis suppurativa, an inflammatory skin condition affecting the apocrine sweat glands and hair follicles, presented for evaluation of discoloration of bilateral sclera, nail beds, and gingiva. Ophthalmic evaluation revealed intact visual acuity, diffuse blue-gray hyperpigmentation of the sclera, more pronounced overlying insertions of the horizontal muscles, without any scleral thinning. Macular optical coherence tomography and fundus exam revealed a blue hue to the underlying choroid with dark deposits in the retinal pigment epithelium. Despite drug discontinuation, after six years the discoloration persisted. Management was directed towards patient tolerability.
Keywords: hyperpigmentation; minocycline; ocular ochronosis; retinal pigment epithelium deposits; scleral hyperpigmentation.
Copyright © 2023, Baaklini et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures




References
-
- UpToDate. Waltham: UpToDate; [ Oct; 2022 ]. 2023. Minocycline (systemic): drug information.
-
- Minocycline-induced scleral pigmentation. Fraunfelder FT, Randall JA. Ophthalmology. 1997;104:936–938. - PubMed
Publication types
LinkOut - more resources
Full Text Sources